沉默APN对胶质瘤细胞U251增殖、侵袭和凋亡的影响

董云朋; 程远; 陈晋

doi:10.16016/j.1000-5404.201912238

您当前的位置：

首页 >

文章列表页 >

沉默APN对胶质瘤细胞U251增殖、侵袭和凋亡的影响

基础医学 | 更新时间：2026-01-09

- 沉默APN对胶质瘤细胞U251增殖、侵袭和凋亡的影响
- Effects of silencing APN gene on proliferation, invasion and apoptosis of human glioma U251 cells
- 第三军医大学学报 2020年42卷第9期页码：908-914
- 作者机构：
  
  400010 重庆, 重庆医科大学附属第二医院神经外科
- 作者简介：
  
  [陈晋，E-mail：chenjin@hospital.cqmu.edu.cnCHEN Jin, E-mail: chenjin@hospital.cqmu.edu.cn
- 基金信息：
  
  国家自然科学基金面上项目(81401505)
- DOI：10.16016/j.1000-5404.201912238
  中图分类号： R394.3;R730.23;R730.264
- 收稿：2019-12-25，
  
  修回：2020-02-08，
  
  纸质出版：2020-05-15
- 稿件说明：
移动端阅览
董云朋, 程远, 陈晋. 沉默APN对胶质瘤细胞U251增殖、侵袭和凋亡的影响[J]. 第三军医大学学报, 2020,42(9):908-914.

Yunpeng DONG, Yuan CHENG, Jin CHEN. Effects of silencing APN gene on proliferation, invasion and apoptosis of human glioma U251 cells[J]. Journal of Third Military Medical University, 2020, 42(9): 908-914.
董云朋, 程远, 陈晋. 沉默APN对胶质瘤细胞U251增殖、侵袭和凋亡的影响[J]. 第三军医大学学报, 2020,42(9):908-914. DOI： 10.16016/j.1000-5404.201912238.

Yunpeng DONG, Yuan CHENG, Jin CHEN. Effects of silencing APN gene on proliferation, invasion and apoptosis of human glioma U251 cells[J]. Journal of Third Military Medical University, 2020, 42(9): 908-914. DOI： 10.16016/j.1000-5404.201912238.

摘要

目的

探究aminopeptidase N(APN)对胶质瘤细胞U251增殖能力、迁移侵袭能力和凋亡等生物学行为的影响及可能的作用机制。

方法

通过RNA干扰技术沉默胶质瘤细胞U251中APN的表达后

运用RT-qPCR的方法检测APN mRNA表达，采用Western blot检测APN蛋白表达水平，CCK-8检测各组U251细胞的增殖活性；采用流式细胞仪检测细胞凋亡和细胞周期；采用细胞划痕实验检测U251细胞的迁移能力，Transwell实验检测细胞侵袭能力；采用Western blot检测STAT3通路蛋白t-STAT3、p-STAT3、Bcl-2和MMP-2的蛋白表达水平。

结果

与空白对照组和阴性对照组相比，沉默U251中APN的表达后APN在基因和蛋白表达水平下降(

0.01)，沉默APN后U251的增殖活性明显下降(

0.05)，细胞周期停滞在G

期，并且凋亡率明显增加(

0.01)；另外沉默APN的表达后U251细胞的迁移能力和侵袭能力明显下降(

0.01)；沉默APN后STAT3磷酸化水平下降，引起下游蛋白Bcl-2和MMP-2等蛋白表达下降(

0.05)。

结论

沉默APN可通过STAT3信号途径抑制胶质瘤细胞U251增殖、迁移和侵袭，诱导凋亡。

Abstract

Objective

To determine the effect of aminopeptidase N (APN) on the proliferation

invasion

and apoptosis in human glioma U251 cells and to investigate the possible mechanism.

Methods

After APN gene expression was silenced in glioma cells U251 by RNAi

its expression at mRNA and protein levels was detected by RT-qPCR and Western blotting

respectively. Then

CCK-8 assay

flow cytometry

wound healing test and transwell assay were used to detect the proliferation ability

cell cycle and apoptosis

migration and invasion activity in the U251 cells. The protein expression of STAT3 signal pathway proteins t-STAT3

p-STAT3

MMP-2 and Bcl-2 was measured by Western blotting.

Results

Compared with blank control and NC-siRNA cells

the expression of APN was decreased at mRNA and protein levels in APN-siRNA cells (

0.01). Silencing of APN gene also

resulted in inhibited proliferation ability (

0.05)

cell cycle arrested at G

phase

enhanced apoptotic rate (

0.01)

and decreased migration and invasion abilities (

0.01) in U251 cells. What's more

the inhibited expression of p-STAT3 caused the decreased expression of Bcl-2 and MMP-2 (all

0.05).

Conclusion

Silencing of APN could inhibit the proliferation

migration and invasion

and induce apoptosis in glioma U251 cells

via

STAT3 signaling pathway.

关键词

Keywords

references

DIXON J, KAKLAMANIS L, TURLEY H, et al . Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin[J ] . J Clin Pathol, 1994, 47(1): 43-47. DOI:10.1136/jcp.47.1.43.

RESHEQ Y J, MENZNER A K, BOSCH J, et al . Impaired transmigration of myeloid-derived suppressor cells across human sinusoidal endothelium is associated with decreased expression of CD13[J ] . J Immunol, 2017, 199(5): 1672-1681. DOI:10.4049/jimmunol.1600466.

YAMANAKA C, WADA H, EGUCHI H, et al . Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma[J ] . Jpn J Clin Oncol, 2018, 48(1): 52-60. DOI:10.1093/jjco/hyx157.

MARTÍNEZ J M, PRIETO I, RAMÍREZ M J, et al . Aminopeptidase activities in breast cancer tissue[J ] . Clin Chem, 1999, 45(10): 1797-1802. DOI:10.1093/clinchem/45.10.1797.

ISHⅡ K, USUI S, SUGIMURA Y, et al . Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion[J ] . Int J Cancer, 2001, 92(1): 49-54.

ZHANG J, FANG C Y, QU M H, et al . CD13 inhibition enhances cytotoxic effect of chemotherapy agents[J ] . Front Pharmacol, 2018, 9: 1042. DOI:10.3389/fphar.2018.01042.

AFFRONTI M L, HEERY C R, HERNDON J E 2nd, et al . Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy[J ] . Cancer, 2009, 115(15): 3501-3511. DOI:10.1002/cncr.24398.

LIAO A H, CHOU H Y, HSIEH Y L, et al . Enhanced therapeutic epidermal growth factor receptor (EGFR) antibody delivery via pulsed ultrasound with targeting microbubbles for glioma treatment[J ] . J Med Biol Eng, 2015, 35(2): 156-164. DOI:10.1007/s40846-015-0032-9..

WELLER M, WICK W, ALDAPE K, et al . Glioma[J ] . Nat Rev Dis Primers, 2015, 1: 15017. DOI:10.1038/nrdp.2015.17.

HAMID O, ROBERT C, DAUD A, et al . Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma[J ] . N Engl J Med, 2013, 369(2):134-144. DOI: 10.1056/NEJMoa1305133.

BALAR A V, WEBER J S. PD-1 and PD-L1 antibodies in cancer: current status and future directions[J]. Cancer Immunol Immunother, 2017, 66(5): 551-564. DOI:10.1007/s00262-017-1954-6.

FILLEY A C, HENRIQUEZ M, DEY M. Recurrent glioma clinical trial, CheckMate-143: the game is not over yet[J]. Oncotarget, 2017, 8(53): 91779-91794. DOI:10.18632/oncotarget.21586.

GRUPP S A, KALOS M, BARRETT D, et al . Chimeric antigen receptor-modified T cells for acute lymphoid leukemia[J ] . N Engl J Med, 2013, 368(16): 1509-1518. DOI:10.1056/NEJMoa1215134.

SCHUSTER S J, SVOBODA J, CHONG E A, et al . Chimeric antigen receptor T cells in refractory B-cell lymphomas[J ] . N Engl J Med, 2017, 377(26): 2545-2554. DOI:10.1056/nejmoa1708566.

WEI X R, LAI Y X, LI J, et al . PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells[J ] . Oncoimmunology, 2017, 6(3): e1284722. DOI:10.1080/2162402x.2017.1284722.

HECKLER M, DOUGAN S K. Unmasking pancreatic cancer: epitope spreading after single antigen chimeric antigen receptor T-cell therapy in a human phase Ⅰ trial[J]. Gastroenterology, 2018, 155(1): 11-14. DOI:10.1053/j.gastro.2018.06.023.

陈峰, 郑晓红, 李文斌.脑胶质瘤免疫治疗进展[J].首都医科大学学报, 2019, 40(6): 966-971.

CHEN F, ZHENG X H, LI W B. Immunotherapy for the treatment of glioma[J]. J Cap Med Univ, 2019, 40(6): 966-971.

PIEDFER M, DAUZONNE D, TANG R P, et al . Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells[J ] . FASEB J, 2011, 25(8): 2831-2842. DOI:10.1096/fj.11-181396.

WANG X Q, LIU Y, LIU W, et al . Ubenimex, an APN inhibitor, could serve as an antitumor drug in RT112 and 5637 cells by operating in an Aktassociated manner[J ] . Mol Med Rep, 2018, 17: 4531-4539. DOI:10.3892/mmr.2018.8402.

TERAUCHI M, KAJIYAMA H, SHIBATA K, et al . Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells[J ] . BMC Cancer, 2007, 7: 140. DOI:10.1186/1471-2407-7-140.

WANG R, SUN Q, WANG P, et al . Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells[J ] . Oncotarget, 2016, 7(5): 5754-5768. DOI:10.18632/oncotarget.6805.

SAIKI I, FUJⅡ H, YONEDA J, et al . Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation[J ] . Int J Cancer, 1993, 54(1): 137-143. DOI:10.1002/ijc.2910540122.

BRANTLEY E C, BENVENISTE E N. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas[J]. Mol Cancer Res, 2008, 6(5): 675-684. DOI:10.1158/1541-7786.mcr-07-2180.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

GSK-J4通过抑制STAT3磷酸化对HepG2肝癌细胞凋亡和侵袭的影响

神经降压素及其受体1对胶质瘤细胞侵袭的影响

可调控STAT3干扰载体抑制BIU-87细胞侵袭的体外研究

细胞外ATP对U87胶质瘤细胞生长和侵袭的作用

LncRNA FGD5-AS1通过调节miR-302b-3p/E2F1轴对胃癌细胞迁移及侵袭的影响